These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
171 related articles for article (PubMed ID: 32504279)
41. An adipocyte-specific defect in oxidative phosphorylation increases systemic energy expenditure and protects against diet-induced obesity in mouse models. Choi MJ; Jung SB; Lee SE; Kang SG; Lee JH; Ryu MJ; Chung HK; Chang JY; Kim YK; Hong HJ; Kim H; Kim HJ; Lee CH; Mardinoglu A; Yi HS; Shong M Diabetologia; 2020 Apr; 63(4):837-852. PubMed ID: 31925461 [TBL] [Abstract][Full Text] [Related]
42. Mitochondrial DNA depletion syndrome: new descriptions and the use of citrate synthase as a helpful tool to better characterise the patients. Navarro-Sastre A; Tort F; Garcia-Villoria J; Pons MR; Nascimento A; Colomer J; Campistol J; Yoldi ME; López-Gallardo E; Montoya J; Unceta M; Martinez MJ; Briones P; Ribes A Mol Genet Metab; 2012 Nov; 107(3):409-15. PubMed ID: 22980518 [TBL] [Abstract][Full Text] [Related]
43. Diseases caused by nuclear genes affecting mtDNA stability. Suomalainen A; Kaukonen J Am J Med Genet; 2001; 106(1):53-61. PubMed ID: 11579425 [TBL] [Abstract][Full Text] [Related]
44. The impact of LDLR function on fibroblast growth factor 21 levels. Besseling J; Ong KL; Huijgen R; Rye KA; Hovingh GK; Hutten BA; Lambert G Atherosclerosis; 2015 Aug; 241(2):322-5. PubMed ID: 26068142 [TBL] [Abstract][Full Text] [Related]
45. Autosomal disorders of mitochondrial DNA maintenance. Van Goethem G Acta Neurol Belg; 2006 Jun; 106(2):66-72. PubMed ID: 16898256 [TBL] [Abstract][Full Text] [Related]
47. The Interplay between Mitochondrial Morphology and Myomitokines in Aging Sarcopenia. Romanello V Int J Mol Sci; 2020 Dec; 22(1):. PubMed ID: 33374852 [TBL] [Abstract][Full Text] [Related]
49. Skeletal muscle increases FGF21 expression in mitochondrial disorders to compensate for energy metabolic insufficiency by activating the mTOR-YY1-PGC1α pathway. Ji K; Zheng J; Lv J; Xu J; Ji X; Luo YB; Li W; Zhao Y; Yan C Free Radic Biol Med; 2015 Jul; 84():161-170. PubMed ID: 25843656 [TBL] [Abstract][Full Text] [Related]
50. Fibroblast growth factor 21 is an early predictor of acute-on-chronic liver failure in critically ill patients with cirrhosis. Ruiz-Margáin A; Pohlmann A; Ryan P; Schierwagen R; Chi-Cervera LA; Jansen C; Mendez-Guerrero O; Flores-García NC; Lehmann J; Torre A; Macías-Rodríguez RU; Trebicka J Liver Transpl; 2018 May; 24(5):595-605. PubMed ID: 29476704 [TBL] [Abstract][Full Text] [Related]
51. Plasma Gelsolin Reinforces the Diagnostic Value of FGF-21 and GDF-15 for Mitochondrial Disorders. Peñas A; Fernández-De la Torre M; Laine-Menéndez S; Lora D; Illescas M; García-Bartolomé A; Morales-Conejo M; Arenas J; Martín MA; Morán M; Domínguez-González C; Ugalde C Int J Mol Sci; 2021 Jun; 22(12):. PubMed ID: 34203775 [TBL] [Abstract][Full Text] [Related]
52. Differential roles of GDF15 and FGF21 in systemic metabolic adaptation to the mitochondrial integrated stress response. Kang SG; Choi MJ; Jung SB; Chung HK; Chang JY; Kim JT; Kang YE; Lee JH; Hong HJ; Jun SM; Ro HJ; Suh JM; Kim H; Auwerx J; Yi HS; Shong M iScience; 2021 Mar; 24(3):102181. PubMed ID: 33718833 [TBL] [Abstract][Full Text] [Related]
53. Mitochondrial mutations: genotype to phenotype. Schon EA; DiMauro S Novartis Found Symp; 2007; 287():214-25; discussion 226-33. PubMed ID: 18074641 [TBL] [Abstract][Full Text] [Related]
54. Fibroblast growth factor-21 and omentin-1 hepatic mRNA expression and serum levels in morbidly obese women with non-alcoholic fatty liver disease. Waluga M; Kukla M; Zorniak M; Kajor M; Liszka L; Dyaczynski M; Kowalski G; Zadlo D; Waluga E; Olczyk P; Buldak RJ; Berdowska A; Hartleb M J Physiol Pharmacol; 2017 Jun; 68(3):363-374. PubMed ID: 28820393 [TBL] [Abstract][Full Text] [Related]
55. Serum concentrations and tissue expression of a novel endocrine regulator fibroblast growth factor-21 in patients with type 2 diabetes and obesity. Mraz M; Bartlova M; Lacinova Z; Michalsky D; Kasalicky M; Haluzikova D; Matoulek M; Dostalova I; Humenanska V; Haluzik M Clin Endocrinol (Oxf); 2009 Sep; 71(3):369-75. PubMed ID: 19702724 [TBL] [Abstract][Full Text] [Related]
56. Metformin-induced inhibition of the mitochondrial respiratory chain increases FGF21 expression via ATF4 activation. Kim KH; Jeong YT; Kim SH; Jung HS; Park KS; Lee HY; Lee MS Biochem Biophys Res Commun; 2013 Oct; 440(1):76-81. PubMed ID: 24041694 [TBL] [Abstract][Full Text] [Related]
57. Fibroblast growth factor 21: a novel biomarker for human muscle-manifesting mitochondrial disorders. Suomalainen A Expert Opin Med Diagn; 2013 Jul; 7(4):313-7. PubMed ID: 23782039 [TBL] [Abstract][Full Text] [Related]
58. Fibroblast growth factor 21 (FGF21) is a sensitive marker of osteoporosis in haemodialysis patients: a cross-sectional observational study. Zhu L; Li M; Zha Q; Yang M; Yu J; Pan M; Yin Q; Jiang L; Xia M; Liu BC; Wang B BMC Nephrol; 2021 May; 22(1):183. PubMed ID: 34011291 [TBL] [Abstract][Full Text] [Related]
59. Diverse Changes of Circulating Fibroblast Growth Factor 21 Levels in Hepatitis B Virus-Related Diseases. Wu L; Pan Q; Wu G; Qian L; Zhang J; Zhang L; Fang Q; Zang G; Wang Y; Lau G; Li H; Jia W Sci Rep; 2017 Nov; 7(1):16482. PubMed ID: 29184085 [TBL] [Abstract][Full Text] [Related]
60. FGF21 expression and release in muscle cells: involvement of MyoD and regulation by mitochondria-driven signalling. Ribas F; Villarroya J; Hondares E; Giralt M; Villarroya F Biochem J; 2014 Oct; 463(2):191-9. PubMed ID: 25055037 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]